Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind placebo-controlled trial of Qingyan Lihou Capsule for acute pharyngitis
CTR20262684Phase 3Active
- Sponsor
- Inner Mongolia Minzu University College of Mongolian Medicine
- Start
- Jul 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Qingyan Lihou Capsule in acute pharyngitis, sponsored by Inner Mongolia Minzu University College of Mongolian Medicine. Started Jul 2026; status: active.
02
Drugs
Qingyan Lihou Capsule
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on CTR20262684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262684.